HomeBiotech

Biotech

WuXi Biologics Included in Hang Seng ESG 50 Index

WuXi Biologics Included in Hang Seng ESG 50 Index

September 23, 2024

European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare

European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare

September 22, 2024

Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs

Preclinical Research with Advanced Oncology Models and Immuno-oncology Services by Altogen Labs

September 21, 2024

Synthetic Biology Market to Grow by USD 55.60 billion (2024-2028), AI Driven Innovations Boost Adoption and Market Revenue – Technavio Report

Synthetic Biology Market to Grow by USD 55.60 billion (2024-2028), AI Driven Innovations Boost Adoption and Market Revenue – Technavio Report

September 20, 2024

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

September 19, 2024

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

September 18, 2024

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

September 17, 2024

Trailhead Biosystems Announces Joshua Snow as Chief Commercial Officer

Trailhead Biosystems Announces Joshua Snow as Chief Commercial Officer

September 16, 2024

Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024

Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024

September 15, 2024

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

September 14, 2024

« 1 … 8 9 10 11 12 … 17 »